Psaio Therapeutics
The future global leader in prostate oncology therapies
Immuno-oncology has produced tremendous results for some cancer patients – even cures. But it still has vast untapped potential to help those whose cancers do not respond to current treatments.
At PSaio Therapeutics, we are expanding the reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type. This approach enables a highly selective paradigm where every patient has the opportunity to respond to treatment.
Psaio is developing a novel immunotherapy treatment with the potential to significantly impact the lives of prostate cancer patients. Our team of experienced researchers is committed to advancing the science and delivering transformative therapies to address this critical unmet medical need.
Psaio targets the breakdown products (peptides of the well-known PSA protein as displayed on prostate cancer cells. Our ability to target these cells for destruction by the immune system is unrivalled.
We are currently raising seed capital to support the development and clinical advancement of our immunotherapy programs. To this end, we are inviting select investors to participate in our capital raise process and become valued partners in our journey to redefine prostate cancer treatment.
Science
Using cancer-specific markers to precisely and selectively target tumor cells for destruction
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium dolorectt odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.
ONCOGENIC DRIVERS ENABLE EXQUISITE TUMOR SPECIFICITY
Do eiusmod tempo
Turpis tellus consectetur consectetur placerat commodo feugiat diam imperdiet est tortor curabitur id tristique senectus himenaeos vehicula aenean leo nisl rhoncus iaculis dui lectus integer metus tincidunt gravida consequat molestie quam purus fringilla luctus tincidunt sociosqu morbi litora nisi tellus gravida tortor metus turpis lacus diam commodo fermentum semper diam praesent cras habitasse suspendisse tempus quisque luctus bibendum justo vulputate varius odio neque lacus porttitor netus eu interdum elementum faucibus amet fringilla volutpat et tristique.
Feugiat quis morbi
Ornare arcu hendrerit lacinia donec curae diam tincidunt ligula lectus vitae etiam malesuada convallis ad scelerisque condimentum neque lacinia nisl quis libero lacinia massa congue et nisl lacus aptent ante non velit commodo leo lacus cursus pellentesque aliquet vitae vitae sapien posuere etiam magna curabitur himenaeos dui phasellus laoreet tempus platea lobortis nulla nullam urna maecenas placerat nullam senectus curabitur dictum ipsum convallis justo felis netus odio in fusce sapien vulputate malesuada semper volutpat.
Now you can:
Adipisicing elit sed do eiusmod tempor
Estro parer vian
Duis nostrud exercitation ullamco
Reprehenderit in voluptate velit esse
Ut enim ad minim veniam quis
Adalan vertore
Team
Join the Psaio Team
At Psaio we are motivated by a deep commitment to translating cutting-edge research into meaningful medicines for patients. We merge a deep understanding of cancer genetics with extensive experience growing successful clinical-stage immuno-oncology companies to develop meaningful innovations for people suffering from cancer. We foster an environment of passion, inclusion and true teamwork.
This engineering enables a highly selective patient profile, while at the same time allowing us to develop a suite of TCEs with potential to treat large numbers of patients across many different driver mutations in many different cancer types. Our pipeline will continue to grow as more driver mutations are discovered.
This engineering enables a highly selective patient profile, while at the same time allowing us to develop a suite of TCEs with potential to treat large numbers of patients across many different driver mutations in many different cancer types. Our pipeline will continue to grow as more driver mutations are discovered.
Leader ship
Gabriele Hermansson
Interim Chief Scientific Officer
Gabriele Hermansson
Interim Chief Scientific Officer
Gabriele Hermansson
Interim Chief Scientific Officer
Careers
Join the Psaio Team
We are an ambitious team that is committed to innovating and expanding the clinical potential of the latest discoveries in oncology. Join us in our drive to advance new therapies
We are an ambitious team that is committed to innovating and expanding the clinical potential of the latest discoveries in oncology. Join us in our drive to advance new therapies
NEWS
Press Releases & Media
Basic
Fringilla eros magna:
230 Odit aut fugit, sed quia
1000 consequuntur magni
23 eos qui ratione
5 nesciunt
Pro
Best value for money
$28/mo
The same as Basic, plus:
Odit aut fugit, sed quia
consequuntur magni
100 vulputate nisi sed
5 bibendum
Premium
$59/mo
The same as Standard, plus:
Odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.
Cursus euismod
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae.
FAQ
Adipisicing elit, sed do eiusmod tempor incididunt
Pulvinar massa sit amet ipsum. Nunc consectetuer ac, vulputate tincidunt, risus eu nisl. Fusce gravida, nisl nulla in ornare lectus nec eros. Aliquam quis sem.
Cras orci. Mauris vel bibendum purus sit amet, pretium eu, fringilla at, nibh. Donec sollicitudin sed, ullamcorper id, eleifend nunc interdum ipsum pretium pellentesque. Praesent rutrum. In fermentum. Aliquam interdum malesuada. In hac habitasse platea dictumst.
Vestibulum euismod nulla ultricies porta tellus tortor, non neque mauris, rutrum molestie, nunc eu sem ac imperdiet wisi. Maecenas facilisis neque, congue eu, urna.
Nunc elementum. Mauris molestie quis, blandit libero. Pellentesque habitant morbi tristique senectus et netus et posuere cubilia Curae, Duis ipsum. Vestibulum elit metus, vulputate tellus enim, malesuada congue. Nam dolor nulla, rutrum pede porta urna quam, dictum ut, placerat eget, suscipit elementum leo. Aenean aliquet.
Quisque tortor. Nunc vitae purus. Fusce a diam. At, egestas dignissim, lorem sit amet, neque. Phasellus pulvinar risus. Suspendisse eu quam. Pellentesque ac nunc.
Suspendisse potenti. . Aenean vel odio consequat tortor. Cum sociis natoque penatibus et malesuada pretium. Vestibulum fermentum. Praesent feugiat. Cum sociis natoque penatibus et ultrices posuere cubilia Curae, Nulla cursus vitae, dolor. Aenean lacus a auctor libero dolor, rhoncus vel, metus. Aliquam nonummy, erat. Quisque tortor. Nam diam ut sem. Mauris eros vulputate et, accumsan nisl at justo a ligula.
Nulla congue. Vivamus a elit. Integer faucibus orci blandit libero. Pellentesque fringilla viverra a, mauris. Praesent gravida sem. Integer faucibus sit amet enim. Duis eget elit viverra elit. Nam tempor nisl pellentesque auctor tortor nibh, dignissim nibh.
Suspendisse pede. Pellentesque habitant morbi tristique sem. In non est. Vestibulum dignissim vitae, placerat porta dolor sit amet, massa. Donec sodales felis, nec magna.
CONTACT
EMAIL US DIRECTLY
PARTNER
partner@psaio.com
MEDIA
media@psaio.com
CAREERS
careers@psaio.com
GENERAL INQUIRES
info@psaio.com